巴西福塔莱萨一家三级儿科转诊医院从儿童和青少年中分离出的艰难梭菌菌株的分子流行病学和抗菌药耐药性

IF 3 4区 医学 Q2 INFECTIOUS DISEASES Brazilian Journal of Infectious Diseases Pub Date : 2024-05-01 DOI:10.1016/j.bjid.2024.103767
Hildenia Baltasar Ribeiro Nogueira , Cecília Leite Costa , Carlos Quesada-Gómez , Dvison de Melo Pacífico , Eliane de Oliveira Ferreira , Renata Ferreira de Carvalho Leitão , Gerly Anne de Castro Brito
{"title":"巴西福塔莱萨一家三级儿科转诊医院从儿童和青少年中分离出的艰难梭菌菌株的分子流行病学和抗菌药耐药性","authors":"Hildenia Baltasar Ribeiro Nogueira ,&nbsp;Cecília Leite Costa ,&nbsp;Carlos Quesada-Gómez ,&nbsp;Dvison de Melo Pacífico ,&nbsp;Eliane de Oliveira Ferreira ,&nbsp;Renata Ferreira de Carvalho Leitão ,&nbsp;Gerly Anne de Castro Brito","doi":"10.1016/j.bjid.2024.103767","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><p><em>C. difficile</em> has been increasingly reported as a cause of gastrointestinal disease in children, ranging from mild self-limiting diarrhea to severe conditions such as pseudomembranous colitis and toxic megacolon. Only two pediatric research groups reported the presence of <em>C. difficile</em> infection in Brazilian children, but no previous research has examined <em>C. difficile</em> infection among children in northeastern Brazil. This prospective cross-sectional study investigated the molecular epidemiology and antimicrobial resistance of <em>C. difficile</em> strains isolated from children and adolescents with diarrhea referred to a tertiary pediatric hospital in Brazil while exploring the associated risk factors.</p></div><div><h3>Results</h3><p>Toxin positivity or <em>C. difficile</em> isolation was found in 30.4 % (17/56) samples. <em>C. difficile</em> was isolated from 35 % (6/17) samples. Four toxigenic strains were identified (tpi+, tcdA+, tcdB+, cdtB-, without tcdC deletions) belonging to PCR ribotypes and PFGE-pulsotypes: 046 (new pulsotype 1174), 106 (NAP11), 002 (new pulsotype 1274), 012 (new pulsotype NML-1235). Two of the six isolates belonging to ribotypes 143 and 133 were non-toxigenic. All toxigenic strains were sensitive to metronidazole and vancomycin. Regarding the clinical manifestation, diarrhea lasted an average of 11 days, ranging from 3 to 50 days and was often associated with mucus and/or blood. All six patients from whom the <em>C. difficile</em> was isolated had a chronic disease diagnosis, with these comorbidities as the main risk factors.</p></div><div><h3>Conclusion</h3><p>Our study enhances our understanding of the present epidemiological landscape of <em>C. difficile</em>-associated diarrhea (CDI) among children in northeastern Brazil, reveling a substantial CDI frequency of 30.4 %, with toxigenic strains detected in 76.4 % of cases, highlighting a higher prevalence compared to earlier Brazilian studies. In the globalized world, an understanding of disease-generating strains, the associated risk factors, clinical manifestation, and antimicrobial sensitivity has fundamental epidemiological importance and draws attention to preventive measures, allowing for more decisive action.</p></div>","PeriodicalId":56327,"journal":{"name":"Brazilian Journal of Infectious Diseases","volume":null,"pages":null},"PeriodicalIF":3.0000,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1413867024000503/pdfft?md5=ee9aa3ee3077336214e8815c4bee1eb7&pid=1-s2.0-S1413867024000503-main.pdf","citationCount":"0","resultStr":"{\"title\":\"Molecular epidemiology and antimicrobial resistance in Clostridioides difficile strains isolated from children and adolescents in a tertiary referral pediatric hospital in Fortaleza, Brazil\",\"authors\":\"Hildenia Baltasar Ribeiro Nogueira ,&nbsp;Cecília Leite Costa ,&nbsp;Carlos Quesada-Gómez ,&nbsp;Dvison de Melo Pacífico ,&nbsp;Eliane de Oliveira Ferreira ,&nbsp;Renata Ferreira de Carvalho Leitão ,&nbsp;Gerly Anne de Castro Brito\",\"doi\":\"10.1016/j.bjid.2024.103767\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Background</h3><p><em>C. difficile</em> has been increasingly reported as a cause of gastrointestinal disease in children, ranging from mild self-limiting diarrhea to severe conditions such as pseudomembranous colitis and toxic megacolon. Only two pediatric research groups reported the presence of <em>C. difficile</em> infection in Brazilian children, but no previous research has examined <em>C. difficile</em> infection among children in northeastern Brazil. This prospective cross-sectional study investigated the molecular epidemiology and antimicrobial resistance of <em>C. difficile</em> strains isolated from children and adolescents with diarrhea referred to a tertiary pediatric hospital in Brazil while exploring the associated risk factors.</p></div><div><h3>Results</h3><p>Toxin positivity or <em>C. difficile</em> isolation was found in 30.4 % (17/56) samples. <em>C. difficile</em> was isolated from 35 % (6/17) samples. Four toxigenic strains were identified (tpi+, tcdA+, tcdB+, cdtB-, without tcdC deletions) belonging to PCR ribotypes and PFGE-pulsotypes: 046 (new pulsotype 1174), 106 (NAP11), 002 (new pulsotype 1274), 012 (new pulsotype NML-1235). Two of the six isolates belonging to ribotypes 143 and 133 were non-toxigenic. All toxigenic strains were sensitive to metronidazole and vancomycin. Regarding the clinical manifestation, diarrhea lasted an average of 11 days, ranging from 3 to 50 days and was often associated with mucus and/or blood. All six patients from whom the <em>C. difficile</em> was isolated had a chronic disease diagnosis, with these comorbidities as the main risk factors.</p></div><div><h3>Conclusion</h3><p>Our study enhances our understanding of the present epidemiological landscape of <em>C. difficile</em>-associated diarrhea (CDI) among children in northeastern Brazil, reveling a substantial CDI frequency of 30.4 %, with toxigenic strains detected in 76.4 % of cases, highlighting a higher prevalence compared to earlier Brazilian studies. In the globalized world, an understanding of disease-generating strains, the associated risk factors, clinical manifestation, and antimicrobial sensitivity has fundamental epidemiological importance and draws attention to preventive measures, allowing for more decisive action.</p></div>\",\"PeriodicalId\":56327,\"journal\":{\"name\":\"Brazilian Journal of Infectious Diseases\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":3.0000,\"publicationDate\":\"2024-05-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.sciencedirect.com/science/article/pii/S1413867024000503/pdfft?md5=ee9aa3ee3077336214e8815c4bee1eb7&pid=1-s2.0-S1413867024000503-main.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Brazilian Journal of Infectious Diseases\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1413867024000503\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"INFECTIOUS DISEASES\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Brazilian Journal of Infectious Diseases","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1413867024000503","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}
引用次数: 0

摘要

背景据报道,越来越多的儿童因艰难梭菌感染而引发胃肠道疾病,轻则出现自限性腹泻,重则引发假膜性结肠炎和中毒性巨结肠等严重疾病。只有两个儿科研究小组报告了巴西儿童中存在艰难梭菌感染,但此前没有研究对巴西东北部儿童中的艰难梭菌感染进行过调查。这项前瞻性横断面研究调查了从巴西一家三级儿科医院转诊的腹泻儿童和青少年中分离出的艰难梭菌菌株的分子流行病学和抗菌药耐药性,同时探讨了相关的风险因素。35%(6/17)的样本中分离出艰难梭菌。确定了四种致毒菌株(tpi+、tcdA+、tcdB+、cttB-,无 tcdC 缺失),分别属于 PCR 核型和 PFGE 脉冲型:046(新脉冲型 1174)、106(NAP11)、002(新脉冲型 1274)、012(新脉冲型 NML-1235)。属于核糖 143 型和 133 型的六个分离株中有两个不具毒性。所有毒株都对甲硝唑和万古霉素敏感。在临床表现方面,腹泻平均持续 11 天,从 3 天到 50 天不等,通常伴有粘液和/或血液。我们的研究加深了我们对艰难梭菌相关腹泻(CDI)在巴西东北部儿童中的流行病学现状的了解,揭示出艰难梭菌相关腹泻的发病率高达 30.4%,其中 76.4% 的病例中检测到毒株,与巴西早期的研究相比,发病率更高。在全球化的世界中,了解致病菌株、相关风险因素、临床表现和抗菌药敏感性具有重要的流行病学意义,并能引起人们对预防措施的关注,从而采取更果断的行动。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Molecular epidemiology and antimicrobial resistance in Clostridioides difficile strains isolated from children and adolescents in a tertiary referral pediatric hospital in Fortaleza, Brazil

Background

C. difficile has been increasingly reported as a cause of gastrointestinal disease in children, ranging from mild self-limiting diarrhea to severe conditions such as pseudomembranous colitis and toxic megacolon. Only two pediatric research groups reported the presence of C. difficile infection in Brazilian children, but no previous research has examined C. difficile infection among children in northeastern Brazil. This prospective cross-sectional study investigated the molecular epidemiology and antimicrobial resistance of C. difficile strains isolated from children and adolescents with diarrhea referred to a tertiary pediatric hospital in Brazil while exploring the associated risk factors.

Results

Toxin positivity or C. difficile isolation was found in 30.4 % (17/56) samples. C. difficile was isolated from 35 % (6/17) samples. Four toxigenic strains were identified (tpi+, tcdA+, tcdB+, cdtB-, without tcdC deletions) belonging to PCR ribotypes and PFGE-pulsotypes: 046 (new pulsotype 1174), 106 (NAP11), 002 (new pulsotype 1274), 012 (new pulsotype NML-1235). Two of the six isolates belonging to ribotypes 143 and 133 were non-toxigenic. All toxigenic strains were sensitive to metronidazole and vancomycin. Regarding the clinical manifestation, diarrhea lasted an average of 11 days, ranging from 3 to 50 days and was often associated with mucus and/or blood. All six patients from whom the C. difficile was isolated had a chronic disease diagnosis, with these comorbidities as the main risk factors.

Conclusion

Our study enhances our understanding of the present epidemiological landscape of C. difficile-associated diarrhea (CDI) among children in northeastern Brazil, reveling a substantial CDI frequency of 30.4 %, with toxigenic strains detected in 76.4 % of cases, highlighting a higher prevalence compared to earlier Brazilian studies. In the globalized world, an understanding of disease-generating strains, the associated risk factors, clinical manifestation, and antimicrobial sensitivity has fundamental epidemiological importance and draws attention to preventive measures, allowing for more decisive action.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
5.50
自引率
0.00%
发文量
925
审稿时长
41 days
期刊介绍: The Brazilian Journal of Infectious Diseases is the official publication of the Brazilian Society of Infectious Diseases (SBI). It aims to publish relevant articles in the broadest sense on all aspects of microbiology, infectious diseases and immune response to infectious agents. The BJID is a bimonthly publication and one of the most influential journals in its field in Brazil and Latin America with a high impact factor, since its inception it has garnered a growing share of the publishing market.
期刊最新文献
Emerging threat of Oropouche virus in Brazil: an urgent call for enhanced surveillance and response. Detection of Bartonella henselae DNA in Triatoma sordida collected in peridomiciliary environments. Erythema nodosum as first clinical sign of acute Borrelia burgdorferi infection. Soluble isoforms of the DC-SIGN receptor can increase the dengue virus infection in immature dendritic cells. Mycobacterium leprae and Mycobacterium lepromatosis in small mammals in Midwest Brazil.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1